Acceler8 Clinical Research (Asia)’s Post

Day 1 of the 11th Annual Clinical Trials in Oncology Europe 2024! Connect with Alessandro Leggio, Business Development Manager at #OPIS, who is on-site and ready to discuss how OPIS can support your oncology clinical trials. Whether you are looking to explore new opportunities or enhance your current trials, Alessandro is here to offer expert guidance and tailored solutions to help advance your oncology research. Don’t miss the opportunity to connect and discover how we can support the success of your oncology projects. #CTOEU24 #OPIS #OncologyResearch #ClinicalTrials #ClinicalDevelopment

In oncology and hematology, success hinges on designing and executing trials that truly make a difference—from the start. At #SyneosHealth, we deliver the insights that drive impactful outcomes for clinical sites and commercial success. In this video, Wael Harb, VP, Medical Management, Oncology at Syneos Health dives into how we are integrating advancements into our clinical trials, ensuring that the future of hematology/oncology trials continue to improve and become more accessible for all patients. Meet with Wael and the rest of our team at ASH 2024: https://lnkd.in/gcs6JCxZ #SyneosHealthLife #WorkHereMattersEverywhere #ClinicalCareers

This will be a great opportunity to learn about Translational Drug Development (TD2)'s expansion into Europe and our commitment to accelerating #CancerTherapeuticDevelopment from #BenchToBedside. #TD2 #cancertherapeutic #clinicaltrial #clinicaldevelopment #regulatoryconsulting #TheTD2Difference

In oncology and hematology, success hinges on designing and executing trials that truly make a difference—from the start. At #SyneosHealth, we deliver the insights that drive impactful outcomes for clinical sites and commercial success. In this video, Wael Harb, VP, Medical Management, Oncology at Syneos Health dives into how we are integrating advancements into our clinical trials, ensuring that the future of hematology/oncology trials continue to improve and become more accessible for all patients. Meet with Wael and the rest of our team at ASH 2024: https://lnkd.in/gSeEyzVU #SyneosHealthLife #WorkHereMattersEverywhere #ClinicalCareers

Clinical trials are becoming increasingly complex in the rapidly evolving field of oncology. Oncology trials require an oncology CRO with a robust scientific team, deep regulatory knowledge, compassionate understanding of, and dedication to improving the patient experience, as well as the expertise to support clinical sites and investigators in recruiting patients and ensuring their safety. Learn more about ERGOMED's solutions to the challenges of oncology trials: https://lnkd.in/eGrT5Jb2 #ComplexClinicalTrials #ClinicalResearch #PatientCentric #VulnerablePopulations #OncologyCRO

📢 Strategic Implications of Oncology Clinical Trial Design in Early-Phase Studies 📢 Here’s a thought-provoking webinar on the strategic implications of oncology clinical trial design in early-phase studies. Led by Peter Langecker MD PhD, Executive Medical Director, Global Oncology at Caidya, this webinar shed light on how trial design shapes the success of early oncology studies using innovative approaches. If you missed the live session, don't worry! You can access the FREE recording of the webinar here: https://lnkd.in/dfNxmqte. I highly recommend checking out this webinar to gain valuable insights into the intricate world of oncology trial design. In the world of clinical trials, trial design plays a crucial role in determining the outcome of a study. This webinar explored novel approaches such as biomarker stratification, adaptive enrichment designs, outcome-adaptive randomization, and the integration of real-world data. These strategies have the potential to enhance trial outcomes and maximize the chances of success in later phases of research while minimizing risks. One key takeaway from the webinar was the importance of selecting optimal doses and schedules through dose-finding studies in early-phase trials. This is particularly relevant under Project Optimus, where dose expansion requires the identification of the most appropriate dose and schedule for the registrational trial. For professionals in the field of oncology, it is essential to stay updated on the latest trial design strategies and their potential impact on research outcomes. This webinar provides valuable insights into the trade-offs involved in different protocol design options and offered guidance on developing a trial structure that optimizes success while mitigating risks. #ClinicalTrials #OncologyResearch #TrialDesign #EarlyPhaseStudies #WebinarRecording #Caidya #OncologyTreatment #ResearchAdvancements

In oncology and hematology, success hinges on designing and executing trials that truly make a difference—from the start. At #SyneosHealth, we deliver the insights that drive impactful outcomes for clinical sites and commercial success. In this video, Wael Harb, VP, Medical Management, Oncology at Syneos Health dives into how we are integrating advancements into our clinical trials, ensuring that the future of hematology/oncology trials continue to improve and become more accessible for all patients. Meet with Wael and the rest of our team at ASH 2024: https://lnkd.in/gMAXQPKE #SyneosHealthLife #WorkHereMattersEverywhere #ClinicalCareers

💡 Join Syneos Health® for an upcoming webinar to explore insights from oncologists surveyed at the ESMO 2024 conference. #Oncology drug development is advancing rapidly with innovative trials, novel mechanisms of action, and groundbreaking therapies like antibody-drug conjugates (ADCs) and theranostics. 🌟 The featured speakers will highlight the most impactful data from the conference, examining how these cutting-edge treatments are transforming #cancercare. Discover what excites healthcare providers and how the oncology landscape is evolving with personalized medicine and combination therapies. ➡️ Learn more + register here: https://buff.ly/47qHKr6 #DrugDevelopment #ClinicalResearch #OncologyDrugs #OncologyTrials #OncologyClinicalTrials #TherapeuticAreas #OncologyDrugDevelopment #CellAndGeneTherapy

In oncology and hematology, success hinges on designing and executing trials that truly make a difference—from the start. At #SyneosHealth, we deliver the insights that drive impactful outcomes for clinical sites and commercial success. In this video, Wael Harb, VP, Medical Management, Oncology at Syneos Health dives into how we are integrating advancements into our clinical trials, ensuring that the future of hematology/oncology trials continue to improve and become more accessible for all patients. Meet with Wael and the rest of our team at ASH 2024: https://lnkd.in/dqCmw_28 #SyneosHealthLife #WorkHereMattersEverywhere #ClinicalCareers

In oncology and hematology, success hinges on designing and executing trials that truly make a difference—from the start. At #SyneosHealth, we deliver the insights that drive impactful outcomes for clinical sites and commercial success. In this video, Wael Harb, VP, Medical Management, Oncology at Syneos Health dives into how we are integrating advancements into our clinical trials, ensuring that the future of hematology/oncology trials continue to improve and become more accessible for all patients. Meet with Wael and the rest of our team at ASH 2024: https://lnkd.in/eUdGTDhH #SyneosHealthLife #WorkHereMattersEverywhere #ClinicalCareers